Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06399185
PHASE4

Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

Catheter-related bladder discomfort (CRBD) is common in patients awaking from general anesthesia with an urinary catheter. We suppose that that use of dexmedetomidine and/or esketamine during anesthesia may reduce the occurrence of CRBD. This 2x2 factorial randomized trial is designed to explore the effects of esketamine, dexmedetomidine, and their combination on the occurrence CRBD in patients undergoing transurethral urological surgery.

Official title: Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort in Patients Undergoing Transurethral Surgery: a 2 x 2 Factorial Randomized Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1740

Start Date

2024-06-06

Completion Date

2027-05

Last Updated

2025-07-31

Healthy Volunteers

No

Interventions

DRUG

Normal saline

20 ml of normal saline is infused intravenously at 80 ml/h after anesthesia induction but before surgery.

DRUG

Dexmedetomidine

Dexmedetomidine 0.5 μg/kg, diluted with normal salinet o 20 ml, is infused intravenously at 60 ml/h after anesthesia induction but before surgery.

DRUG

Esketamine

Esketamine 0.25 mg/kg, diluted with normal saline to 20 ml, is infused intravenously at 80 ml/h after anesthesia induction but before surgery.

DRUG

Combined dexmedetomidine-esketamine

Dexmedetomidine 0.5 μg/kg and esketamine 0.25 mg/kg, diluted with normal saline to 20 ml, is infused intravenously at 80 ml/h after anesthesia induction but before surgery.

Locations (2)

Peking University First Hospital

Beijing, Beijing Municipality, China

Peking University Shenzhen Hospital

Shenzhen, Guangdong, China